Literature DB >> 3767694

Estradiol-17 beta affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta.

A L Lin, R Gonzalez, K D Carey, S A Shain.   

Abstract

We used the synthetic estrogen R2858 (moxestrol) and estradiol-17 beta, respectively, to characterize the estrogen receptor in baboon (Papio sp.) aortic or myocardial cytoplasmic and nuclear preparations. We observed regional differences in the cytoplasmic fraction estrogen and progesterone receptor content of aortic arch, thoracic aorta, and abdominal aorta when tissues from either oophorectomized or oophorectomized estradiol-17 beta-treated subjects were compared. The estrogen receptor content was highest in the abdominal aorta and lowest in the aortic arch. In contrast, the cytoplasmic fraction progesterone receptor content was highest in the aortic arch and lowest in the abdominal aorta. The nuclear fraction estrogen receptor could not be demonstrated in preparations from cardiovasculature of oophorectomized female baboons. The use of Silastic implants to administer a physiologic concentration of estradiol-17 beta to oophorectomized female baboons caused a 20% to 50% reduction in cytoplasmic fraction estrogen receptor content, which was quantitatively accounted for by the appearance of estrogen receptor in the corresponding nuclear aortic or myocardial preparation. Estrogen administration caused a 20% to 40% increase in cytoplasmic fraction progesterone receptor content in both myocardium and aorta; however, differences were significant only for abdominal aorta (p less than 0.05). Estradiol-17 beta treatment caused a tenfold increase in uterine cytoplasmic fraction progesterone receptor content in treated as compared to oophorectomized control females, suggesting that baboon cardiovasculature is less sensitive to changes in endogenous estrogen concentration than is uterus. The ability of estradiol-17 beta to affect apparent intracellular distribution of baboon cardiovascular estrogen receptors and to elevate cytoplasmic fraction progesterone receptor content suggests that these estrogen receptors are physiologically functional and indicates that estrogen may directly regulate primate cardiovascular cell function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767694     DOI: 10.1161/01.atv.6.5.495

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  6 in total

Review 1.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

2.  Cardiovascular hemodynamics during stress in premenopausal versus postmenopausal women.

Authors:  Andrew Sherwood; Sat Byul Park; Joel W Hughes; James A Blumenthal; Alan Hinderliter; Ranak Trivedi; Judith McFetridge-Durdle
Journal:  Menopause       Date:  2010-03       Impact factor: 2.953

3.  Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery.

Authors:  R Vargas; B Wroblewska; A Rego; J Hatch; P W Ramwell
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

4.  Aortic elastic properties in young pregnant women.

Authors:  Rifat Eralp Ulusoy; Ergun Demiralp; Ata Kirilmaz; Fethi Kilicaslan; Namik Ozmen; Nezihi Kucukarslan; Ejder Kardesoglu; Levent Tutuncu; Ozcan Keskin; Bekir Sitki Cebeci
Journal:  Heart Vessels       Date:  2006-01       Impact factor: 1.814

Review 5.  Migraine in women: the role of hormones and their impact on vascular diseases.

Authors:  Simona Sacco; Silvia Ricci; Diana Degan; Antonio Carolei
Journal:  J Headache Pain       Date:  2012-02-26       Impact factor: 7.277

6.  17Beta-estradiol effects on human coronaries and grafts employed in myocardial revascularization: a preliminary study.

Authors:  Gianluca Polvani; Fabio Barili; Giuseppe Rossoni; Luca Dainese; Manuela Wally Ossola; Veli K Topkara; Francesco Grillo; Eleonora Penza; Elena Tremoli; Paolo Biglioli
Journal:  J Cardiothorac Surg       Date:  2006-12-20       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.